FDAnews
www.fdanews.com/articles/198449-diasorin-earns-ce-mark-for-testosterone-test

DiaSorin Earns CE Mark for Testosterone Test

August 10, 2020

DiaSorin has received a CE mark for its LIAISON Testosterone xt assay for detecting fertility disorders.

The in vitro diagnostic test is a chemiluminescence immunoassay (CLIA) that measures the amount of testosterone in a patient’s serum and plasma.

The company said it has launched the test in Europe, based on a CE mark certification.

View today's stories